Related Experiment Videos
Accredited inflammatory bowel disease units are associated with better patient-reported experience: a cross-sectional
Xavier Calvet1, Anna Puy Guillén2, Úrsula Reales3
1Gastroenterology , Parc Taulí Hospital Universitari, Spain.
Background:
Comprehensive inflammatory bowel disease (IBD) units have been implemented to improve the quality of care delivered to patients with Crohn's disease and ulcerative colitis. Although accreditation programmes have improved structural and process quality indicators, little is known about their association with patients' healthcare experience.
Aim:
To compare patient-reported experience between patients receiving care in accredited and non-accredited IBD units. Secondary objectives were to compare perceived disease activity and selected organisational quality indicators.
Methods:
Cross-sectional online survey conducted among members of the Associació de Malalts de Crohn i Colitis Ulcerosa de Catalunya. The questionnaire included nine prespecified individual PREM indicators previously developed and used by our group, a global five-point satisfaction score, the Manitoba Index and organisational quality indicators. Hospitals were classified as having or not having an accredited IBD unit according to the official information of the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa. Comparisons were performed using univariate analyses.
Results:
A total of 127 valid questionnaires were analysed (95 accredited units; 32 non-accredited units). All nine PREM showed significantly better scores in accredited units. Overall satisfaction was also significantly higher among patients attending accredited units, which also scored better for organisational quality indicators. No statistically significant difference was observed in disease activity measured by the Manitoba Index.
Conclusions:
Accredited IBD units are associated with substantially better patient-reported experience without statistically significant differences in patient-reported disease activity. These findings provide patient-centred evidence supporting this model of care.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
01:26Inflammatory Bowel Disease I: Introduction
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...